At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
EVAX Evaxion Biotech A/S
Trading 11-10 10:54:51 EST
2.72
-0.03
-1.03%
High2.90Low2.72Vol47.30K
Open2.80D1 Closing2.75Amplitude6.48%
Mkt Cap25.10MTradable Cap17.86MTotal Shares9.22M
T/O133.81KT/O Rate0.72%Tradable Shares6.56M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX), Align Tech (ALGN) and Edwards Lifesciences (EW)
TIPRANKS  ·  02:00
Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX), Align Tech (ALGN) and Edwards Lifesciences (EW)
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
MT Newswires Live  ·  00:13
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
Evaxion Files Amendment to Registration Statement Related to 2025 Eib Debt Settlement Agreement
THOMSON REUTERS  ·  11-09 21:00
Evaxion Files Amendment to Registration Statement Related to 2025 Eib Debt Settlement Agreement
Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement
GlobeNewswire  ·  11-09 21:00
Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
MT Newswires Live  ·  11-07
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
Evaxion Reports EVX-01 Induces Strong Immune Responses in Phase 2 Melanoma Trial
Reuters  ·  11-07
Evaxion Reports EVX-01 Induces Strong Immune Responses in Phase 2 Melanoma Trial
Evaxion a/S - Data Highlights Strong Predictive Performance of Evaxion's AI-Immunology Platform
THOMSON REUTERS  ·  11-07
Evaxion a/S - Data Highlights Strong Predictive Performance of Evaxion's AI-Immunology Platform
New Phase 2 Data Highlight the Strength of the Immune Response Induced by Personalized Cancer Vaccine Evx-01
THOMSON REUTERS  ·  11-07
New Phase 2 Data Highlight the Strength of the Immune Response Induced by Personalized Cancer Vaccine Evx-01
New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
GlobeNewswire  ·  11-07
New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
MT Newswires Live  ·  11-06
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
Evaxion’s EVX-01 Melanoma Study Reaches a Key Update—What Investors Should Know
TIPRANKS  ·  11-05
Evaxion’s EVX-01 Melanoma Study Reaches a Key Update—What Investors Should Know
Evaxion Reports New Data Supporting EVX-04 Vaccine for Acute Myeloid Leukemia
Reuters  ·  11-04
Evaxion Reports New Data Supporting EVX-04 Vaccine for Acute Myeloid Leukemia
Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting
GlobeNewswire  ·  11-04
Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting
Evaxion to Present Phase 2 Biomarker Data for Cancer Vaccine EVX-01 at SITC 2026
Reuters  ·  11-03
Evaxion to Present Phase 2 Biomarker Data for Cancer Vaccine EVX-01 at SITC 2026
Evaxion's EVX-01 Shows Durable Clinical Outcomes in Three-Year Phase 2 Melanoma Data
Reuters  ·  10-30
Evaxion's EVX-01 Shows Durable Clinical Outcomes in Three-Year Phase 2 Melanoma Data
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
GlobeNewswire  ·  10-30
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
MT Newswires Live  ·  10-27
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
MT Newswires Live  ·  10-26
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Bioline RX Ltd Sponsored ADR (BLRX) and Evaxion Biotech (EVAX)
TIPRANKS  ·  10-24
Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Bioline RX Ltd Sponsored ADR (BLRX) and Evaxion Biotech (EVAX)
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
MT Newswires Live  ·  10-23
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

Introduction

Company Name.
Evaxion Biotech A/S
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
Issue price:
--